Kestra Medical Technologies, LTD Schedule 13G passive stakes

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 10.2% of Kestra Medical Technologies' common stock as of March 31, 2026.

T. Rowe Price Associates, Inc. has reported a 7.5% beneficial ownership stake in Kestra Medical Technologies common stock.

FMR LLC and Abigail P. Johnson have disclosed an aggregate beneficial ownership of 10.2% of Kestra Medical Technologies Inc.'s common stock as of September 30, 2025.

Bain Charger Holdings, L.P., an affiliate of Bain Capital, has disclosed a beneficial ownership of 52.6% in Kestra Medical Technologies, Ltd., primarily through shared voting and dispositive power.

Endeavour Medtech Growth II LP, Endeavour Medtech Growth II Parallel LP, and Endeavour Medtech II GP Limited have collectively reported a beneficial ownership of 5.2% in Kestra Medical Technologies, Ltd.'s common shares.

FMR LLC and its affiliates, along with Abigail P. Johnson, have reported a combined beneficial ownership of 6.3% of Kestra Medical Technologies Inc.'s common stock as of March 31, 2025.